Dyah Erti Mustikawati

Similar documents
PPM Subgroup Meeting: Lille

Public Private Mix sub group meeting 23 October, 2011 Scale up PPM in Myanmar

Strategy of TB laboratories for TB Control Program in Developing Countries

Progress and plans on PPM in TB Control in South-East Asia Region. Dr Md Khurshid Alam Hyder Regional Adviser-TB WHO/SEARO

Country experience on engaging large hospitals - INDIA

Republic of Indonesia

Priority programmes and rural retention the example of TB. Karin Bergstrom Stop TB Department WHO, Geneva

Subaward for Patient-Based Organization to Increase Community Awareness and Reduce TB-Related Stigma in DKI Jakarta

Philippine Strategic TB Elimination Plan: Phase 1 (PhilSTEP1)

TB CARE I - Indonesia. Year 3. Annual Report. Period. October 1, 2012 September 30, 2013

Programmatic Management of MDR-TB in China: Progress, Plan and Challenge

MONITORING AND EVALUATION PLAN

Scaling up PPM: lessons from design and implementation of the Global Fund TB grants

Importance of the laboratory in TB control

Engagement of Workplace in TB Care and Control in Bangladesh. Dr. Md. Nazrul Islam Program Manager NTP Bangladesh

TUBERCULOSIS CONTROL RESEARCH MATRIX

Sub Award for Professional Organizations for District Based PPM for Puskesmas and Hospitals in DKI Jakarta

Financial impact of TB illness

PATIENT CENTERED APPROACH

WHO Task Force Framework on assessment of surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO / STB /TME June 2010

NATIONAL SITUATION ASSESSMENT

Summary of the Evaluation Study

USAID Cooperative Agreement No. AID-OAA-A

Assessment of the performance of TB surveillance in Indonesia main findings, key recommendations and associated investment plan

Systematic Engagement of Hospitals Philippine Experience. Dr. Marl Mantala 8 th PPM Sub-group Meeting, 10 Nov. 2012, Kuala Lumpur

Author's response to reviews

Universal Access to MD TB Program in Cambodia. ITM, Antwerp 08 December Sam Sophan Cambodian Health Committee (CHC)

OPERATIONAL RESEARCH. What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg

Tuberculosis control

Engaging the Private Retail Pharmaceutical Sector in TB Case Finding in Tanzania: Pilot Dissemination Meeting Report

Assessment of the fraction of cases being missed by routine TB notification data, based on the "Onion" model

Epidemiological review of TB disease in Sierra Leone

Improving the estimates of childhood TB disease burden and assessing childhood TB activities at country level

Sub-Award for Professional Organization to Implement Mandatory Notification for TB in North Sumatra USAID Cooperative Agreement No. AID-OAA-A

Changing the paradigm of Programmatic Management of Drug-resistant TB

RIT/ JATA Philippines, Inc. Activities and Accomplishments. STOP TB Partnership Forum Asia March 14-15, 2016

Terms of Reference Kazakhstan Health Review of TB Control Program

DOC An Action Plan for TB and Poverty. Introduction

Tuberculosis surveillance in Suriname. Drs. B. Jubithana, MD M. Wongsokarijo, MSc

Role of Technical Assistance in the Establishment and Scale Up of Programmatic Management of Drug Resistant Tuberculosis (PMDT) in Ethiopia

Role of National TB Program in LTBI Reseach. Dr Hung, Vietnam

Indonesia. National TB. Program. Current status of integrated community based TB service delivery and the Global

PPM PMDT LINKAGE A TOOLKIT

Regional Meeting of National TB Control Programme Managers and Partners Bangkok, Thailand, September

Regional Response Plan for Programmatic Management of Drug-resistant Tuberculosis

Prevention and Care- Role of Pharmacists. Prafull Sheth, FIP Vice President

Business Coalitions- Mediators for TB care and control

Progress in implementation of prevalence surveys in the 21 global focus countries: an overview of achievements, challenges and next steps

Invest for Impact: Global Fund Session. 29 th Stop TB Partnership Coordinating Board Meeting Berlin 17 th May

Momentum on Child TB: South East Asia (SEA)

PROGRAM YEAR 1 First and Second Quarterly Performance Monitoring Report October 1 st, 2010 March 31 st, 2011

Is the private sector prepared to engage in MDR-TB management? Findings from the Philippines. Tauhid Islam WHO/WPRO

USAID s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program ( )

LEVELS AND METHODS OF PUBLIC FINANCING OF TB SERVICE IN ARMENIA

Primary-care based interventions for informal sector workforce

Engaging Private Drug Outlets in TB Case Finding: Tanzania Experience. Jumanne Marko Mkumbo Program Pharmacists Bangkok, March 2-6, 2015

Public-Private Partnerships for TB Control

Linking Social Support with Pillar 2/ Universal Health Coverage component of the End TB strategy

Hospital engagement lessons from the five-country WHO/CIDA initiative

Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India

Update on Lab services in the African region including new diagnostics

Accelerating scale up of MDR-TB treatment in TB CARE countries

Executive summary. 1. Background and organization of the meeting

Request for Proposals. For. Sub-award. in support of. Challenge TB East Africa Region. Cross Border TB initiative

End-Term Comprehensive External Review of the Ghana National Tuberculosis Health Sector Strategic Plan

Tuberculosis Diagnosis and Treatment Computer-based Training Package for Indonesia

Sustainable Financing to Ensure Access for All to TB Medicines

Toolkit to develop a national strategic plan for TB prevention, care and control

Support, Capacity building and sustainability. Group (2)

Checklists for screening for active tuberculosis in high-risk groups

Expanding Laboratory Capacity in India for the Diagnosis of Drug-Resistant TB

GLOBAL FUND ROUND 6 TB GRANT CLOSURE REPORT

National Tuberculosis Control Programme: Democratic People s Republic of Korea

Data Collection Report WHO PEN Disease Interventions Economic Evaluation Indonesia

ENGAGE-TB. Operational Guidance M&E. Paris, 2 November ENGAGE-TB Operational Guidance November 2, 2013

Government takes over TB medicines supply in Moldova: way forward

MANAGING AND MONITORING THE TB PROGRAMME

FEDERAL MINISTRY OF HEALTH

Empowering States & Districts & using biometric technology to deliver healthcare to the doorsteps of the poor

Meeting Report ELEVENTH NATIONAL TB PROGRAMME MANAGERS MEETING IN THE WESTERN PACIFIC REGION March 2017 Tokyo, Japan

KEY ACTIVITIES IN TB CONTROL. Using Epidemiology for Data-Driven Decision-Making in Tuberculosis Programs February 24, 2016

TB CONTROL STRATEGIC PLAN FOR GHANA

Grant Aid Projects/Standard Indicator Reference (Health)

Challenge TB Year 1 Performance Monitoring Report October 1, 2014 March 31, 2015

South-East Asia. Regional response framework for DR-TB World Health Organization Regional Office for South-East Asia

USG funding for partners to support countries in implementing Global Fund TB grants. Andrea Braza Godfrey, TBTEAM Secretariat 25 June 2010, Geneva

The Green Light Committee Progress Report

NEPAD Planning and Coordinating Agency. Southern Africa Tuberculosis and Health Systems Support Project Project ID: P155658

REQUIRED DOCUMENT FROM HIRING UNIT

Minister. Secretaries of State. Department of Planning and Health Information. Department of Human Resources Development

REPORT OF THE NINTH MEETING

STRATEGIC OBJECTIVES & ACTION PLAN. Research, Advocacy, Health Promotion & Surveillance

Country Coordinating Mechanism The Global Fund to Fight AIDS, Tuberculosis, and Malaria Indonesia (CCM Indonesia)

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012)

In , WHO technical cooperation with the Government is expected to focus on the following WHO strategic objectives:

PhilHealth TB DOTS Out-patient Benefit Package

FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017

SEA/HSD/305. The Regional Six-point Strategy for Health Systems Strengthening based on the Primary Health Care Approach

Health Cluster Coordination Meeting. Friday December 4, 2015, Kiev

Terms of Reference (TORs) and other job details are available on the department website cfw.ap.nic.in

Transcription:

SCALING UP PPM IN INDONESIA Seventh Meeting of the Subgroup on Public-Private Mix for TB Care and Control 23-24 October 2011, Lille, France Dyah Erti Mustikawati NTP Manager MOH Indonesia

Content Background Situation Strategy Challenges Conclusion

Background Situation Strategy Challenges Conclusion

INDONESIA General Information Total Population 234.181.405 (Projection 2009, BPS) Islands 17.000 Number of Districts 399 Number of Cities 98 Number of Sub Districts 6.652 Number of Villages 77.012 Type of Health Care Facilities TOTAL DOTS Health Centre 9.549 9.161 PRM/PPM/PS 1.914/2.746/4.467 Chest Clinic 28 28 Lung Hospital 9 8 Hospital 1.627 639 (39,27%) - Public Hospital 533 315 - Parastatal/Own State Hospital 63 22 - Military-Police Hospital 155 73 - Private Hospital 867 221

5 Country with TB Burden (Global Tuberculosis Control, 2011) 1. India (2,300,000) 2. China (1,000,000) 3. South Africa (490,000) 4. Indonesia (450,000) 5. Pakistan (400,000) 400.000-500.000 New Cases per year, 61000 Died by years (Global Tuberculosis Control 2011)

Global report 2011: Rank 9

MDG s Indicator Achievement for TB Incidence, Prevalence & Mortality TB, 1990, 2007 *) & 2009 **) TB cases Incidence all type TB Prevalence all cases 1990 2007 2009 2010 Per year Per 100.000 pop Per day Per year Per 100.000 pop Per day Per year Per 100.000 pop Per day Per year Per 100.000 pop 626.867 343 1.717 528.063 228 1.447 430 189 (45%) 1.178 430 189 (45%) 809.592 443 ~ 565.614 244 ~ 660 285 (36%) ~ 660 289 (35%) Per day 1.178 ~ Incidence new smear + cases 282.09 154 773 236.029 102 647 NA NA NA NA NA NA Mortality 168.956 92 463 91.369 39 250 61 27 (70%) 167 61 27 (70%) 167 *) Global Report TB, 2009 page 282 **) Global Report TB, 2010 page 171 ***)Global report 2011

BACK GROUND INFORMATION PPM in Indonesia has involved various health providers such as hospitals, prison, workplace/ industry, PPs, Health insurance, Ministry of Defence, Police but not yet in systematic approach PPM initiated first in hospitals and Lung Clinics/hospitals (Hospital DOTS Linkage) because the greater potential role played by the hospital in providing better outputs (institutional approach) in 2000 In coordination with JAMSOSTEK since 2010 provided TB DOTS services to 159.811 companies with about 13 million workers and families in the country, but until 2011 implementation still limited in 2 big provinces (DKI Jakarta & West Java) PT ASKES is also involved in procurement of standard national TB Drugs JAMKESMAS and JAMKESDA provided the treatment cost for poor TB patients

PPM TOOL-KIT FOR SCALE-UP PPM IN INDONESIA BASIC TOOLS OF PPM IMPLEMENTASION TOOLS 1. Rationale & generic approach 2. National situation assessment ACCEPTABLE/ USEFULL v v ENGAGEMENTOF SPESIFIC TYPES OF CARE PROVIDERS TOOLS 8. Engaging private practitioners ACCEPTABLE/ USEFULL 9. Engaging Hospitals v 10. Engaging NGO s v v 3. Operational guidelines 4.ACSM 5. M & E v 6. ISTC v 7. Resources & budgeting v v v 11. Engaging Workplaces 12. Engaging Social Security Organizations 13. Engagement for TB/HIV collaboration 14. Engagement for PMDT v v Esp : Health Insurance schemes (HIS) v v

Background Situation Strategy Challenges Conclusion

CASE DETECTION AND TREATMENT SUCCESS RATE, INDONESIA 1995-2011*) 100 90 80 70 60 91 81 54 58 73.8 87 86 86.1 86.7 89.5 91 91 91 91 91.2 68 75.7 69.8 72.8 73.1 88.4 SR Q- 2 78.3 50 54 40 30 20 10 0 1.4 4.6 7.5 12 19 20 21 30.6 37.6 CDR Q -2 41.3 year *) Q- 2 CDR SR Target CDR RPJMN 73%, Global 70% Target SR RPJMN & Global 85%

% CONTRIBUTION TO TB CASE DETECTION by HEALTH FACILITIES 2010 100% 80% 60% 40% 20% 0% NSS (+) NSS (-) EP retreatment NGO 37 0 0 0 PPs 705 568 47 9 Workplace 78 154 12 4 Prisons 88 35 9 12 Lung clinic 3725 5416 449 276 Hospital 15869 18152 3246 1151 PHC 162864 76922 7896 5137 Health facilities PHC Hospital Lung clinic Prisons Workplace PPs NGO

ENROLLMENT For PPs PILOT PROJECT by PDPI (OCT 2010 SEP 2011) Total TB cases from 23 pulmonologists in private hospital/clinic 1000 887 800 600 427 400 200 TB Program Drugs Prescribed Drugs Total 1314 patients *)From total 1314 patients= 1130 Pulmonary TB patients (adult) (+) 146 Extra pulmonary TB 38 TB on children Number of patients underwent sputum examination (for diagnosis) Area Number of Pulmonary TB patients (Adult) Number of patients with sputum smear examination (+) result (-) result Central Jakarta 391 356 (91%) 164 (46%) 192 (54%) East Jakarta 304 232 (76%) 77 (33 %) 155 (67%) South Jakarta 435 312 (72%) 144 (46%) 168 (54%)

Background Situation Strategy Challanges Conclusion

Scaling up engagement of all care providers INDONESIA

STRATEGIES To enhance expansion of quality DOTS To address TB/HIV, MDR-TB, Childhood TB, the needs of poor population and other vulnerable group To engage all public and private care providers in implementation of ISTC To empower TB patients and communities To strengthen health system and TB control program management To increase commitment of national and local government To enhance research, development and utilization of strategic information

Number of patients 1 7 Challenges of National TB Control Program in Indonesia 600'000 500'000 400'000 300'000 GAP Estimated ALL TB cases TOTAL notified TB cases New Smear Positives 200'000 100'000 New Smear Negatives Re-treatment - 97 98 99 00 01 02 03 04 05 06 07 08 09 Extra Pulm

HEALTH SEEKING BEHAVIOUR TB PATIENT *NIHRD (2011)

TB Drugs Consumption at Private Market/Sectors* Country Incidence Consumption of TB drugs 1 st line at private market (%) Proportion of loose TB drugs (%) India 1,982,628 117 23 Indonesia 429,730 116 91 Filipina 257,317 86 16 Pakistan 409,392 65 36 China 1,301,322 23 98 Thailand 92,087 17 94 Russia 150,898 13 100 Vietnam 174,593 7 90 Bangladesh 359,671 7 11 Africa Selatan 476,732 3 34 *Wells et al (2011)

2.Public/Private Hospital Services - Approach: Hospital Accreditation, Implementation TB DOTS as Minimum Standard requirement for accreditation of Hospitals - Leading: Directorates of Referral Health Services -TA: KNCV 1.Basic DOTS Services At Puskesmas -Approach: Surveillance System Strengthening and MIFA, Improving quality of care, increasing coverage of TBHIV, reaching un-reach pop at remote are (DTPK), increasing referral to Quality DOTS Services -Leading: NTP -TA: WHO, FHI and other partners 3.Quality DOTS services by Private Practitioners and Specialist - Approach: Implementation of ISTC for all TB care and treatment from all care providers, increasing professional responsibility to cure TB patients, rewarding through cumulative credits mechanism for licensing/certification -Leading: IMA -TA: ATS, 4.Qualified TB Diagnostic -Approach: Strengthening lab network and Quality Assurance (public and private) DST, Culture and Microscopic -Leading: Directorate of Medical Support - TA: KNCV and JATA 6.Community System Strengthening -Function as advocator raise fund and commitment, - Increase public awareness, function as public watch to ensure deliveries of quality services, -increasing awareness of right and responsibility of the patients (patient's charter). -Social Mobilization, suspect identification, increasing demand creation, intensifying the services of TB in slum areas and prison -Leading: NGO, FBO, CSO -TA: FHI, other partners 5.Quality of anti TB Drug Dispensing and rational Use of Drug -Approach: law enforcement, establishment of networking and monitoring system, WHO prequalification -Leading: Indonesian Pharmacist Association, DG of Pharmaceutical Services, Indonesian FDA -TA: USP and MSH

PROGRESS IMPLEMENTATION OF INDONESIAN COMPREHENSIVE PPM MODEL (1) Pilar 1: Basic DOTS Services at PHC (PHC) Pilar 2: Public/Private Hospital DOTS Services 1. Shifting paper based surveillance system to electronic/web based system 2. Improving TBHIV reporting recording so that it can capture core data 3. Increase demand creation for utilization of Basic DOTS in PHC 4. strengthening linkage with NGO's/FBO's to intensify case finding 5. Improved EQA system for smear microscopic examination 6. Improved format data collection and intensify data validation and feedback mechanism 1. Launching policy for accreditation and indicating TB DOTS services as one of the minimum standard requirement for hospital accreditation (as mandated by Hospital law no 44/2009) 2. Development and publication of standard guideline for hospital accreditation 3. Socialization of SOP for accreditation to all provinces and district 4. Appointing Committee for Acreditation (KARS) and instrument for accreditation 5. Planning for full implementation of accreditation by 2012, and all hospital without accreditation will not be allowed to extend their operational license 6. Directorates of Medical Services as SSF-TB SRs is fully in charge for provision and monitoring of hospital accreditation implementation

PROGRESS IMPLEMENTATION OF INDONESIAN COMPREHENSIVE PPM MODEL (2) Pilar 3: PPs DOTS Services Pilar 4:Quality Assured TB Diagostics 1. Implementation of pilot involvement of Pneumologist in DOTS at Jakarta 2. Socialization of ISTC and establishment of ISTC task force in 33 provinces 3. IMA is responsible to ensure the proper involvement of private practitioners in TB treatment in compliance to ISTC. IMA is Srs for SSF TB Indonesia 4. IMA will developed promoting media to remind that the doctor's responsibility is curing the disease not only treating (professional ethical conduct) 5. IMA will develop user friendly reporting recording system for PPs notification and provides scheme for rewarding cumulative credit point for PPs involvent in TB 6. IMA is planning to establish linkage between PPs, private labs and private paharmacyst 1.Establishing External Quality Assurance for Microscopic from 8 Provinces, to national coverage of 33 provinces 2. Improving and stepwise expansion of quality assured DST laboratories 3. Establishing network of QA beyond public services, by including private laboratories services 4.Stepwise Pilot implementation Gene Expert in 17 sites for accelerating the TBMDR confirmation, TB and TBMDR among HIV patients and TB in prisons

PROGRESS IMPLEMENTATION OF INDONESIAN COMPREHENSIVE PPM MODEL (3) Pilar 5:Quality of anti TB Drug and rational Use of Drug Pilar 6: Community System Strengthening Conducting Workshop for WHO praqualification to ensure qualified drug distibuted to patients for FLD (2 times), for SLDs (1 time), supported by USP, Directorates of Pharmaceutical services, IFDA Conducting workshop at national level to Enganging Indonesian Pharmacyst Association in TB control and rational drug use I Indonesian Pharmacyst association agreeable role: integrated Pharmacy Care for TB, Certification and license for Pharmacy practice, monitoring rational drug use of TB drugs, introducing TB in curricula of School of Pharmacyst, initiating professional incentives credits for pharmacyst for their engangement in TB control, advocating TB drugs manufactures etc. IFDA: initiating Pharmaciovigilance/ QA of TB drugs Initiation and establishment of National network of TB affected people to echo their voices and mainstreaming their agenda Empowering NGOs involvement for advocacy and public pressure and watch of other 5 pillars implementation Launching small grants for NGO involvement from SSF TB and focusing their involment in intitutional strengthening for PPM implementation

Background Situation Strategy Challenges Conclusion

MAJOR BARRIERS TO SCALING UP Multiple leading unit for implementation of each pillars complicates the successfull achievement as achievement in each pillars will influence progress in other pillars there should be close coordination and monitoring of each pillars progress. Intensify coordination and collaboration is really needed, however it is sometime very difficult because of each one busy schedule

Background Situation Strategy Challenges Conclusion

Conclusion The main strategy to prevent the epidemic of TB MDR is providing universal access to qualified DOTS by engaging all care providers achieved NTP has to initiate, facilitate and monitor the engagement of all care providers Multi mix financing mechanism should be introduced to ensure sustainability of TB control

THANK YOU